Today's News
Olympics Are A “Wild Card” For Supplement Industry Publicity / The Olympics inspire fitness enthusiasts to improve performance, which could translate to higher sales of legitimate nutritionals, herbals and other dietary supplements, but if athletes blame supplements for drug testing violations, the industry incurs bad publicity and consumer confidence slips. / “The Tan Sheet”
Current Issue:
Jan. 23, 2012
Dietary Supplements
FDA Will Take GMP Inspections To The Next Level / If supplement firms thought FDA inspectors were tough on GMP compliance last year – they ain’t seen nothing yet. FDA investigators are ready to delve into more complex and technical GMP areas after focusing primarily on “surface level areas of GMP compliance” to date, FDA officials warn. / “The Tan Sheet” Jan. 23, 2012
Pfizer Builds Nutrition Site To Grow Vitamin Business / The website nutritionpossible.com is Pfizer’s latest effort to improve its consumer segment, including the Centrum vitamins line. The site also offers a health assessment tool for recommending supplements and lifestyle changes to consumers. / “The Tan Sheet” Jan. 23, 2012
Supplement Trade Groups A “Unified Choir,” Leaders Say / Supplement trade groups discuss the strengths and strategies of multiple voices representing the industry. / “The Tan Sheet” Jan. 23, 2012
Business & Finance
CMP Therapeutics Readies EU Launch With An Eye On The U.S. / CMP Therapeutics talks with large and small pharmas about distributing its micronized nasal spray, branded as Atlantic Secret. EU regulatory approval came seven years after the firm’s launch, but CEO Neil Moray Mackenzie expects much less time before a U.S. launch. / “The Tan Sheet” Jan. 23, 2012
Valeant Includes OTCs In Bid For Dramatic Growth By 2013 / The Ontario-based firm has its sights set on becoming a top-15 pharma company with a $50 billion market capitalization by the end of 2013. Emerging markets and consumer health products, including the recent iNova and Fleming deals, play a big part in Valeant’s plans. / “The Tan Sheet” Jan. 23, 2012
Recalls
FDA Recalls For Jan. 18 /
DRUGS CLASS II
Excedrin Extra Strength (acetaminophen 250 mg, aspirin 250 mg, caffeine 65 mg) caplets, 100-count caplets per bottle, NDC 0067-2000-91, UPC 3 0067-2000-91 0. Excedrin Migraine (acetaminophen 250 mg, aspirin 250 mg, caffeine 65 mg) caplets, 250-count caplets per bottle, NDC 0067-2039-07, UPC 3 0067-2039-07 1. / “The Tan Sheet” Jan. 23, 2012
News in Brief
In Brief /
Natural Health Team makes illegal drug claims
Supplement maker Natural Health Team makes claims for 14 products that cause them to be drugs, FDA’s New Orleans district office says in a Dec. 28 warning letter. The agency reviewed the firm’s website and book, “A Physician’s Guide to Natural Health Products That Work,” and found claims including “Omega 3 fatty acids have the ability to make blood less likely to clot thus warding off heart attacks and strokes” and “Autism and schizophrenia have been helped by [Nanonized Detoxifying Formula].” The products also are misbranded because they ar... / “The Tan Sheet” Jan. 23, 2012
FDA
Conflict Of Interest Reform Fight Reignites Following Panel Revelations / Advisory committee conflict of interest reform draws increased attention in the wake of concerns raised about a recent Reproductive Health panel meeting. / “The Tan Sheet” Jan. 23, 2012
Publisher's Spotlight
9th Annual Pharmaceutical Strategic Outlook (PSO) Conference, April 11-13, 2012 /
Join us at PSO 2012 where we will delve into the top issues affecting the pharma industry. Experience a dynamic three days of networking and discussion - with a personal and interactive setting, in-depth on-stage interviews, thought-provoking panels, one-on-one partnering meetings and innovative company presentations by carefully selected biotech companies. / “The Tan Sheet” Jan. 23, 2012
Research & Development
Research & Development In Brief / Nicotine patches may boost memory; folic acid, B12 reduce cognitive decline; omega-3 supplements need at least 60% EPA to ease depression; and vitamin A reduces hearing loss risk. / “The Tan Sheet” Jan. 23, 2012
Other
19th Annual Euro-Biotech Partnering Summit / Publisher’s Spotlight: Join us in Paris, France from May 30-June 1, 2012 for the 19th Annual Euro-Biotech Partnering Summit. This year’s theme is Changing the Business Model: Drawing on Global Examples of Innovation to Find New Products and Maximize Efficiency. / “The Tan Sheet” Jan. 23, 2012